JPRN-UMIN000021983招募中未知
Standard dose of effervescent progesterone vaginal tablet for luteal phase support in frozen embryo transfer cycle - SHIFT study
Sanno Hospital0 个研究点目标入组 400 人开始时间: 2016年4月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Patients who had a history of oversensitivity, abnormal uterine bleeding of undetermined origin, missed abortion, ectopic pregnancy, severe hepatic disorder, breast cancer, genital cancer and porphyria, and are under breast-feeding.
研究者
相似试验
进行中（未招募）
1 期
Rectally administered micronized progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle – non-inferiority randomized controlled trialInfertilityCTIS2023-504616-15-02Region Midtjylland618
进行中（未招募）
1 期
Rectally administered micronized progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle – non-inferiority randomized controlled trialInfertilityCTIS2023-504616-15-00Region Midtjylland618
已完成
2 期
Vaginal Progesterone effect on pregnancy rate in infertility women with polycystic ovarian syndromeInfertility and Polycystic Ovarian Syndrome.Polycystic ovarian syndromeIRCT201206072967N4Vice chancellor of research, Kashan University of Medical Sciences200
招募中
不适用
Evaluation of the effect of vaginal progesterone administration on ultrasonographic indicators and fetal and pregnancy outcomes of women at high risk of preeclampsiaHigh risk pregnancy.Supervision of high risk pregnancyIRCT20151228025732N72Semnan University of Medical Sciences60
招募中
Unknown
Bioequivalence study of vaginal progesterone suppository 400 mgIRCT20230222057495N4Ati Pharmed pharmaceutical company24